Zubeida Salaam-Dreyer

Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study

Galo A. Goig, Fabrizio Menardo, Zubeida Salaam-Dreyer et al. · The Lancet Microbe · 2023 · 32 citations · Full text

Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study

Helen Cox, Galo A. Goig, Zubeida Salaam-Dreyer et al. · Journal of Clinical Microbiology · 2022 · 26 citations · Full text

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study

Helen Cox, Zubeida Salaam-Dreyer, Galo A. Goig et al. · The Lancet Microbe · 2021 · 21 citations · Full text

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa

Zubeida Salaam-Dreyer, Elizabeth M. Streicher, Frederick A. Sirgel et al. · Antimicrobial Agents and Chemotherapy · 2021 · 18 citations · Full text